Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions

Volume: 245, Issue: 11, Pages: 964 - 969
Published: Apr 19, 2020
Abstract
Early availability of the sequence, the genetic material of SARS-CoV-2 (the virus that causes COVID-19), has prompted efforts towards identifying a safe and effective vaccine in the current public health emergency. To that end, understanding the pathophysiology of disease is crucial for scientists around the world. Since conventional vaccine development and manufacturing may take several years, it is important to think about alternative...
Paper Details
Title
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions
Published Date
Apr 19, 2020
Volume
245
Issue
11
Pages
964 - 969
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.